Humacyte, Inc. Common Stock Stock Prediction
AI-powered sentiment analysis and prediction trends for HUMA, updated each market day.
HUMA AI Sentiment
AI sees no strong directional signal for Humacyte, Inc. Common Stock stock over the next 10 market days.
Prediction date: April 10, 2026
Subscribers see precise scores, buy/sell targets, and full analytics.
About Humacyte, Inc. Common Stock
Humacyte Inc is developing a commercial-stage biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.
Sector
Exchange
Market Cap
$134,765,598
Cap Tier
Employees
184
Headquarters
DURHAM, NC
Listed Since
Aug. 27, 2021
Website
HUMA Sentiment Trend — Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
HUMA Volatility
Humacyte, Inc. Common Stock has shown high price volatility over the last 5 trading days. High volatility means larger price swings — this can present both opportunity and risk for traders.
